MedPage Today

Bipartisan Bill to Lower Insulin Costs Has Diabetes Advocates Hopeful

Advocates expect the young adult population to especially benefit from the bill, since many struggle to get high-quality ...
Public Broadcasting Service (PBS)

Diabetes advocates hold out hope as a bipartisan bill revives efforts to lower insulin costs

A bipartisan group of senators is aiming to relieve high insulin costs with the INSULIN Act, a bill to cap the cost of the ...

Another GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it’s used

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...
Healthcare Packaging

Inclusive Design Is Reshaping Medical Device Packaging for Us All

Transitioning from a disposable, prefilled autoinjector to a reusable pen meant designing for an even better experience.

Autoinjectors Market worth $300.46 billion by 2031 | MarketsandMarkets™

According to MarketsandMarkets™, the Autoinjectors Market is projected to grow from about USD 127.30 billion in 2026 to USD ...
Everyday Health on MSN

Once-a-week insulin shot could be a game changer for type 2 diabetes

Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly ...
PharmiWeb

Insulin Delivery Devices Market Growth, Trends, and Forecast Driven by Rising Diabetes Prevalence and Smart Technologies

The global insulin delivery devices market is experiencing strong expansion as the prevalence of diabetes continues to rise worldwide. Insulin delivery devices play a crucial role in managing blood ...

Insulin Delivery Devices Market Size is Poised to Reach USD 41.00 Billion by 2035 Owing to the Rising Adoption of Insulin Pens Globally | SNS Insider

U.S. Insulin Delivery Devices Market was valued at USD 7.35 billion in 2025 and is expected to reach USD 15.74 billion by 2035 due to the exceptionally high diabetes prevalence.Austin, March 20, 2026 ...
Medscape

FDA Clears App Integrating Glucose Data, Insulin Injections

The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes. Features include real-time glucose data, dose calculations, ...